ID   PDZD7_HUMAN             Reviewed;        1033 AA.
AC   Q9H5P4; D5FJ77; Q8N321;
DT   16-AUG-2005, integrated into UniProtKB/Swiss-Prot.
DT   05-DEC-2018, sequence version 2.
DT   28-JUN-2023, entry version 159.
DE   RecName: Full=PDZ domain-containing protein 7 {ECO:0000305};
GN   Name=PDZD7 {ECO:0000312|HGNC:HGNC:26257};
GN   Synonyms=PDZK7 {ECO:0000312|HGNC:HGNC:26257};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, SUBCELLULAR
RP   LOCATION, INTERACTION WITH ADGRV1 AND USH2A, INVOLVEMENT IN USH2A AND
RP   USH2C, AND ALTERNATIVE SPLICING.
RX   PubMed=20440071; DOI=10.1172/jci39715;
RA   Ebermann I., Phillips J.B., Liebau M.C., Koenekoop R.K., Schermer B.,
RA   Lopez I., Schafer E., Roux A.F., Dafinger C., Bernd A., Zrenner E.,
RA   Claustres M., Blanco B., Nurnberg G., Nurnberg P., Ruland R.,
RA   Westerfield M., Benzing T., Bolz H.J.;
RT   "PDZD7 is a modifier of retinal disease and a contributor to digenic Usher
RT   syndrome.";
RL   J. Clin. Invest. 120:1812-1823(2010).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N.,
RA   Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A.,
RA   Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C.,
RA   Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D.,
RA   Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C.,
RA   Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K.,
RA   Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A.,
RA   Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S.,
RA   McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S.,
RA   Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V.,
RA   Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A.,
RA   Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A.,
RA   Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P.,
RA   Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y.,
RA   Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D.,
RA   Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [6]
RP   STRUCTURE BY NMR OF 76-170.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of first PDZ domain of PDZ domain containing protein
RT   7.";
RL   Submitted (AUG-2007) to the PDB data bank.
RN   [7]
RP   INVOLVEMENT IN DFNB57, TISSUE SPECIFICITY, INTERACTION WITH USH1G, AND
RP   CHROMOSOMAL TRANSLOCATION.
RX   PubMed=19028668; DOI=10.1093/hmg/ddn395;
RA   Schneider E., Marker T., Daser A., Frey-Mahn G., Beyer V., Farcas R.,
RA   Schneider-Ratzke B., Kohlschmidt N., Grossmann B., Bauss K., Napiontek U.,
RA   Keilmann A., Bartsch O., Zechner U., Wolfrum U., Haaf T.;
RT   "Homozygous disruption of PDZD7 by reciprocal translocation in a
RT   consanguineous family: a new member of the Usher syndrome protein
RT   interactome causing congenital hearing impairment.";
RL   Hum. Mol. Genet. 18:655-666(2009).
RN   [8]
RP   INVOLVEMENT IN DFNB57, AND VARIANTS DFNB57 ARG-103; ARG-228; ARG-285;
RP   500-TYR--GLY-517 DEL AND 526-GLN--PRO-1033 DEL.
RX   PubMed=26416264; DOI=10.1002/ajmg.a.37274;
RA   Booth K.T., Azaiez H., Kahrizi K., Simpson A.C., Tollefson W.T.,
RA   Sloan C.M., Meyer N.C., Babanejad M., Ardalani F., Arzhangi S.,
RA   Schnieders M.J., Najmabadi H., Smith R.J.;
RT   "PDZD7 and hearing loss: More than just a modifier.";
RL   Am. J. Med. Genet. A 167A:2957-2965(2015).
RN   [9]
RP   INVOLVEMENT IN DFNB57, AND VARIANT DFNB57 550-GLN--PRO-1033 DEL.
RX   PubMed=26849169; DOI=10.1097/aud.0000000000000278;
RA   Vona B., Lechno S., Hofrichter M.A., Hopf S., Laeig A.K., Haaf T.,
RA   Keilmann A., Zechner U., Bartsch O.;
RT   "Confirmation of PDZD7 as a nonsyndromic hearing loss gene.";
RL   Ear Hear. 37:E238-E246(2016).
RN   [10]
RP   INVOLVEMENT IN DFNB57, AND VARIANT DFNB57 LEU-66.
RX   PubMed=29048736; DOI=10.1002/ajmg.a.38477;
RA   Guan J., Wang H., Lan L., Wang L., Yang J., Xie L., Yin Z., Xiong W.,
RA   Zhao L., Wang D., Wang Q.;
RT   "Novel recessive PDZD7 biallelic mutations in two Chinese families with
RT   non-syndromic hearing loss.";
RL   Am. J. Med. Genet. A 176:99-106(2018).
CC   -!- FUNCTION: In cochlear developing hair cells, essential in organizing
CC       the USH2 complex at stereocilia ankle links. Blocks inhibition of
CC       adenylate cyclase activity mediated by ADGRV1.
CC       {ECO:0000250|UniProtKB:E9Q9W7}.
CC   -!- SUBUNIT: Homodimerizes (via PDZ2 domain). Component of USH2 complex,
CC       composed of ADGRV1, PDZD7, USH2A and WHRN. Interacts (via PDZ domains)
CC       with WHRN; the interaction is direct (By similarity). Interacts with
CC       USH1G (PubMed:19028668). Interacts with ADGRV1 (via the cytoplasmic
CC       region) (PubMed:20440071). Interacts with USH2A (via the cytoplasmic
CC       region) (PubMed:20440071). Interacts with MYO7A (via MyTH4-FERM
CC       domains) (By similarity). {ECO:0000250|UniProtKB:E9Q9W7,
CC       ECO:0000269|PubMed:19028668, ECO:0000269|PubMed:20440071}.
CC   -!- INTERACTION:
CC       Q9H5P4; Q8WXG9: ADGRV1; NbExp=3; IntAct=EBI-20859318, EBI-7851128;
CC       Q9H5P4; O75445: USH2A; NbExp=2; IntAct=EBI-20859318, EBI-9996372;
CC   -!- SUBCELLULAR LOCATION: Cell projection, cilium
CC       {ECO:0000269|PubMed:20440071}. Nucleus {ECO:0000269|PubMed:20440071}.
CC       Cell projection, stereocilium {ECO:0000250|UniProtKB:E9Q9W7}.
CC       Note=Localizes at the ankle region of the stereocilia.
CC       {ECO:0000250|UniProtKB:E9Q9W7}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9H5P4-3; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9H5P4-1; Sequence=VSP_059942, VSP_059943;
CC       Name=3;
CC         IsoId=Q9H5P4-2; Sequence=VSP_059941;
CC   -!- TISSUE SPECIFICITY: Weakly expressed in the inner ear. Expressed in the
CC       retinal pigment epithelium. {ECO:0000269|PubMed:19028668,
CC       ECO:0000269|PubMed:20440071}.
CC   -!- DISEASE: Deafness, autosomal recessive, 57 (DFNB57) [MIM:618003]: A
CC       form of non-syndromic, sensorineural deafness characterized by
CC       symmetric, bilateral hearing loss with onset in early childhood.
CC       Vestibular function is preserved. Sensorineural deafness results from
CC       damage to the neural receptors of the inner ear, the nerve pathways to
CC       the brain, or the area of the brain that receives sound information.
CC       DFNB57 severity ranges from moderate to severe.
CC       {ECO:0000269|PubMed:19028668, ECO:0000269|PubMed:26416264,
CC       ECO:0000269|PubMed:26849169, ECO:0000269|PubMed:29048736}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Note=A chromosomal aberration disrupting PDZD7 has been found
CC       in patients with non-syndromic sensorineural deafness. Translocation
CC       t(10;11),t(10;11). {ECO:0000269|PubMed:19028668}.
CC   -!- DISEASE: Usher syndrome 2C (USH2C) [MIM:605472]: USH is a genetically
CC       heterogeneous condition characterized by the association of retinitis
CC       pigmentosa with sensorineural deafness. Age at onset and differences in
CC       auditory and vestibular function distinguish Usher syndrome type 1
CC       (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3).
CC       USH2 is characterized by congenital mild hearing impairment with normal
CC       vestibular responses. {ECO:0000269|PubMed:20440071}. Note=The disease
CC       is caused by variants affecting distinct genetic loci, including the
CC       gene represented in this entry. A PDZD7 mutation has been found in
CC       combination with a mutation in ADGRV1 in a patient affected by Usher
CC       syndrome, suggesting PDZD7 mutations contribute to digenic Usher
CC       syndrome. {ECO:0000269|PubMed:20440071}.
CC   -!- DISEASE: Usher syndrome 2A (USH2A) [MIM:276901]: USH is a genetically
CC       heterogeneous condition characterized by the association of retinitis
CC       pigmentosa with sensorineural deafness. Age at onset and differences in
CC       auditory and vestibular function distinguish Usher syndrome type 1
CC       (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3).
CC       USH2 is characterized by congenital mild hearing impairment with normal
CC       vestibular responses. {ECO:0000269|PubMed:20440071}. Note=The gene
CC       represented in this entry acts as a disease modifier.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; FJ617449; ACU45386.1; -; mRNA.
DR   EMBL; AK026862; BAB15577.1; -; mRNA.
DR   EMBL; AL133215; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC029054; AAH29054.1; -; mRNA.
DR   CCDS; CCDS31269.1; -. [Q9H5P4-1]
DR   CCDS; CCDS73182.1; -. [Q9H5P4-3]
DR   RefSeq; NP_001182192.1; NM_001195263.1. [Q9H5P4-3]
DR   RefSeq; NP_079171.1; NM_024895.4. [Q9H5P4-1]
DR   RefSeq; XP_011538479.1; XM_011540177.2. [Q9H5P4-3]
DR   PDB; 2EEH; NMR; -; A=81-167.
DR   PDB; 7PC5; X-ray; 1.70 A; A=858-953.
DR   PDBsum; 2EEH; -.
DR   PDBsum; 7PC5; -.
DR   AlphaFoldDB; Q9H5P4; -.
DR   SMR; Q9H5P4; -.
DR   BioGRID; 123024; 9.
DR   ComplexPortal; CPX-2821; USH2 complex.
DR   CORUM; Q9H5P4; -.
DR   IntAct; Q9H5P4; 4.
DR   STRING; 9606.ENSP00000480489; -.
DR   iPTMnet; Q9H5P4; -.
DR   PhosphoSitePlus; Q9H5P4; -.
DR   BioMuta; PDZD7; -.
DR   DMDM; 73621380; -.
DR   jPOST; Q9H5P4; -.
DR   MassIVE; Q9H5P4; -.
DR   PaxDb; Q9H5P4; -.
DR   PeptideAtlas; Q9H5P4; -.
DR   Antibodypedia; 31245; 72 antibodies from 13 providers.
DR   DNASU; 79955; -.
DR   Ensembl; ENST00000370215.7; ENSP00000359234.3; ENSG00000186862.20. [Q9H5P4-1]
DR   Ensembl; ENST00000619208.6; ENSP00000480489.1; ENSG00000186862.20. [Q9H5P4-3]
DR   GeneID; 79955; -.
DR   KEGG; hsa:79955; -.
DR   MANE-Select; ENST00000619208.6; ENSP00000480489.1; NM_001195263.2; NP_001182192.1.
DR   UCSC; uc001kso.3; human. [Q9H5P4-3]
DR   AGR; HGNC:26257; -.
DR   CTD; 79955; -.
DR   DisGeNET; 79955; -.
DR   GeneCards; PDZD7; -.
DR   HGNC; HGNC:26257; PDZD7.
DR   HPA; ENSG00000186862; Group enriched (brain, intestine, pituitary gland).
DR   MalaCards; PDZD7; -.
DR   MIM; 276901; phenotype.
DR   MIM; 605472; phenotype.
DR   MIM; 612971; gene.
DR   MIM; 618003; phenotype.
DR   neXtProt; NX_Q9H5P4; -.
DR   OpenTargets; ENSG00000186862; -.
DR   Orphanet; 231178; Usher syndrome type 2.
DR   PharmGKB; PA142671189; -.
DR   VEuPathDB; HostDB:ENSG00000186862; -.
DR   eggNOG; KOG3528; Eukaryota.
DR   GeneTree; ENSGT00950000183002; -.
DR   HOGENOM; CLU_304541_0_0_1; -.
DR   InParanoid; Q9H5P4; -.
DR   OMA; LPVNGFP; -.
DR   OrthoDB; 2962072at2759; -.
DR   PhylomeDB; Q9H5P4; -.
DR   TreeFam; TF325033; -.
DR   PathwayCommons; Q9H5P4; -.
DR   SignaLink; Q9H5P4; -.
DR   BioGRID-ORCS; 79955; 22 hits in 1152 CRISPR screens.
DR   EvolutionaryTrace; Q9H5P4; -.
DR   GenomeRNAi; 79955; -.
DR   Pharos; Q9H5P4; Tbio.
DR   PRO; PR:Q9H5P4; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; Q9H5P4; protein.
DR   Bgee; ENSG00000186862; Expressed in right hemisphere of cerebellum and 117 other tissues.
DR   ExpressionAtlas; Q9H5P4; baseline and differential.
DR   Genevisible; Q9H5P4; HS.
DR   GO; GO:0005929; C:cilium; IDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; HDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0002141; C:stereocilia ankle link; ISS:UniProtKB.
DR   GO; GO:0002142; C:stereocilia ankle link complex; ISS:UniProtKB.
DR   GO; GO:0032420; C:stereocilium; ISS:UniProtKB.
DR   GO; GO:0032426; C:stereocilium tip; IBA:GO_Central.
DR   GO; GO:1990696; C:USH2 complex; ISS:ComplexPortal.
DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR   GO; GO:0060117; P:auditory receptor cell development; ISS:UniProtKB.
DR   GO; GO:0060088; P:auditory receptor cell stereocilium organization; ISS:UniProtKB.
DR   GO; GO:0050910; P:detection of mechanical stimulus involved in sensory perception of sound; ISS:UniProtKB.
DR   GO; GO:0051649; P:establishment of localization in cell; IEA:Ensembl.
DR   GO; GO:0045184; P:establishment of protein localization; ISS:UniProtKB.
DR   GO; GO:0060113; P:inner ear receptor cell differentiation; NAS:ComplexPortal.
DR   GO; GO:0007605; P:sensory perception of sound; IBA:GO_Central.
DR   CDD; cd07358; HN_PDZD7_like; 1.
DR   CDD; cd00992; PDZ_signaling; 3.
DR   Gene3D; 1.20.1160.20; -; 1.
DR   Gene3D; 2.30.42.10; -; 3.
DR   InterPro; IPR001478; PDZ.
DR   InterPro; IPR036034; PDZ_sf.
DR   InterPro; IPR042786; PDZD7_HN-like.
DR   PANTHER; PTHR23116; PDZ DOMAIN CONTAINING WHIRLIN AND HARMONIN-RELATED; 1.
DR   PANTHER; PTHR23116:SF29; PDZ DOMAIN-CONTAINING PROTEIN 7; 1.
DR   Pfam; PF00595; PDZ; 3.
DR   SMART; SM00228; PDZ; 3.
DR   SUPFAM; SSF50156; PDZ domain-like; 3.
DR   PROSITE; PS50106; PDZ; 3.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell projection;
KW   Chromosomal rearrangement; Cilium; Deafness; Disease variant;
KW   Non-syndromic deafness; Nucleus; Reference proteome; Repeat;
KW   Retinitis pigmentosa; Usher syndrome.
FT   CHAIN           1..1033
FT                   /note="PDZ domain-containing protein 7"
FT                   /id="PRO_0000058297"
FT   DOMAIN          86..168
FT                   /note="PDZ 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   DOMAIN          210..293
FT                   /note="PDZ 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   DOMAIN          862..934
FT                   /note="PDZ 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   REGION          323..380
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          444..464
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          754..864
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          943..1033
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        323..341
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        986..1033
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   VAR_SEQ         508..1033
FT                   /note="AGGVGPVQKFVTWRLRRDQERGRALLSARSGSPSSQLPNVDEQVQAWESRRP
FT                   LIQDLAQRLLTDDEVLAVTRHCSRYVHEGGIEDLVRPLLAILDRPEKLLLLQDIRSVVA
FT                   PTDLGRFDSMVMLVELEAFEALKSRAVRPPALRPARQDTPPKRHLITPVPDSRGGFYLL
FT                   PVNGFPEEEDNGELRERLGALKVSPSASAPRHPHKGIPPLQDVPVDAFTPLRIACTPPP
FT                   QLPPVAPRPLRPNWLLTEPLSREHPPQSQIRGRAQSRSRSRSRSRSRSSRGQGKSPGRR
FT                   SPSPVPTPAPSMTNGRYHKPRKARPPLPRPLDGEAAKVGAKQGPSESGTEGTAKEAAMK
FT                   NPSGELKTVTLSKMKQSLGISISGGIESKVQPMVKIEKIFPGGAAFLSGALQAGFELVA
FT                   VDGENLEQVTHQRAVDTIRRAYRNKAREPMELVVRVPGPSPRPSPSDSSALTDGGLPAD
FT                   HLPAHQPLDAAPVPAHWLPEPPTNPQTPPTDARLLQPTPSPAPSPALQTPDSKPAPSPR
FT                   IP -> EMGAT (in isoform 3)"
FT                   /id="VSP_059941"
FT   VAR_SEQ         508..517
FT                   /note="AGGVGPVQKF -> EMGVSPCCPG (in isoform 2)"
FT                   /id="VSP_059942"
FT   VAR_SEQ         518..1033
FT                   /note="Missing (in isoform 2)"
FT                   /id="VSP_059943"
FT   VARIANT         66
FT                   /note="R -> L (in DFNB57; unknown pathological
FT                   significance; dbSNP:rs1426679303)"
FT                   /evidence="ECO:0000269|PubMed:29048736"
FT                   /id="VAR_080820"
FT   VARIANT         103
FT                   /note="G -> R (in DFNB57; dbSNP:rs148695069)"
FT                   /evidence="ECO:0000269|PubMed:26416264"
FT                   /id="VAR_080821"
FT   VARIANT         228
FT                   /note="G -> R (in DFNB57; dbSNP:rs753034799)"
FT                   /evidence="ECO:0000269|PubMed:26416264"
FT                   /id="VAR_080822"
FT   VARIANT         285
FT                   /note="M -> R (in DFNB57; dbSNP:rs1554835827)"
FT                   /evidence="ECO:0000269|PubMed:26416264"
FT                   /id="VAR_080823"
FT   VARIANT         500..1033
FT                   /note="Missing (in DFNB57)"
FT                   /evidence="ECO:0000269|PubMed:26416264"
FT                   /id="VAR_080824"
FT   VARIANT         526..1033
FT                   /note="Missing (in DFNB57)"
FT                   /evidence="ECO:0000269|PubMed:26416264"
FT                   /id="VAR_081066"
FT   VARIANT         550..1033
FT                   /note="Missing (in DFNB57)"
FT                   /evidence="ECO:0000269|PubMed:26849169"
FT                   /id="VAR_081067"
FT   CONFLICT        449
FT                   /note="Missing (in Ref. 4; AAH29054)"
FT                   /evidence="ECO:0000305"
FT   STRAND          87..89
FT                   /evidence="ECO:0007829|PDB:2EEH"
FT   STRAND          93..96
FT                   /evidence="ECO:0007829|PDB:2EEH"
FT   STRAND          98..102
FT                   /evidence="ECO:0007829|PDB:2EEH"
FT   STRAND          105..108
FT                   /evidence="ECO:0007829|PDB:2EEH"
FT   STRAND          111..116
FT                   /evidence="ECO:0007829|PDB:2EEH"
FT   HELIX           121..125
FT                   /evidence="ECO:0007829|PDB:2EEH"
FT   STRAND          132..136
FT                   /evidence="ECO:0007829|PDB:2EEH"
FT   HELIX           146..154
FT                   /evidence="ECO:0007829|PDB:2EEH"
FT   STRAND          157..165
FT                   /evidence="ECO:0007829|PDB:2EEH"
FT   STRAND          860..865
FT                   /evidence="ECO:0007829|PDB:7PC5"
FT   STRAND          874..877
FT                   /evidence="ECO:0007829|PDB:7PC5"
FT   STRAND          889..893
FT                   /evidence="ECO:0007829|PDB:7PC5"
FT   HELIX           898..902
FT                   /evidence="ECO:0007829|PDB:7PC5"
FT   STRAND          910..914
FT                   /evidence="ECO:0007829|PDB:7PC5"
FT   HELIX           924..936
FT                   /evidence="ECO:0007829|PDB:7PC5"
FT   STRAND          942..948
FT                   /evidence="ECO:0007829|PDB:7PC5"
SQ   SEQUENCE   1033 AA;  111752 MW;  F267D0911E73ECBC CRC64;
     MAQGFAVGFD PLGLGDLSSG SLSSLSSRGH LGSDSGSTAT RYLLRKQQRL LNGPPRGIRA
     SSPMGRVILI NSPIEANSDE SDIIHSVRVE KSPAGRLGFS VRGGSEHGLG IFVSKVEEGS
     SAERAGLCVG DKITEVNGLS LESTTMGSAV KVLTSSSRLH MMVRRMGRVP GIKFSKEKTT
     WVDVVNRRLV VEKCGSTPSD TSSEDGVRRI VHLYTTSDDF CLGFNIRGGK EFGLGIYVSK
     VDHGGLAEEN GIKVGDQVLA ANGVRFDDIS HSQAVEVLKG QTHIMLTIKE TGRYPAYKEM
     VSEYCWLDRL SNGVLQQLSP ASESSSSVSS CASSAPYSSG SLPSDRMDIC LGQEEPGSRG
     PGWGRADTAM QTEPDAGGRV ETWCSVRPTV ILRDTAIRSD GPHPGRRLDS ALSESPKTAL
     LLALSRPRPP ITRSQSYLTL WEEKQQRKKE KSGSPGEKGA LQRSKTLMNL FFKGGRQGRL
     ARDGRREAWT LDSGSLAKTY PRLDIEKAGG VGPVQKFVTW RLRRDQERGR ALLSARSGSP
     SSQLPNVDEQ VQAWESRRPL IQDLAQRLLT DDEVLAVTRH CSRYVHEGGI EDLVRPLLAI
     LDRPEKLLLL QDIRSVVAPT DLGRFDSMVM LVELEAFEAL KSRAVRPPAL RPARQDTPPK
     RHLITPVPDS RGGFYLLPVN GFPEEEDNGE LRERLGALKV SPSASAPRHP HKGIPPLQDV
     PVDAFTPLRI ACTPPPQLPP VAPRPLRPNW LLTEPLSREH PPQSQIRGRA QSRSRSRSRS
     RSRSSRGQGK SPGRRSPSPV PTPAPSMTNG RYHKPRKARP PLPRPLDGEA AKVGAKQGPS
     ESGTEGTAKE AAMKNPSGEL KTVTLSKMKQ SLGISISGGI ESKVQPMVKI EKIFPGGAAF
     LSGALQAGFE LVAVDGENLE QVTHQRAVDT IRRAYRNKAR EPMELVVRVP GPSPRPSPSD
     SSALTDGGLP ADHLPAHQPL DAAPVPAHWL PEPPTNPQTP PTDARLLQPT PSPAPSPALQ
     TPDSKPAPSP RIP
//
